Form 4: Rapport Therapeutics COO Sells Shares
Insider Transaction (Form 4)
Cheryl Gault, Chief Operating Officer of Rapport Therapeutics, Inc., sold 10,000 shares of common stock on September 30, 2026.
Summary
- Open-market sale: disposed of 7,925 Common Stock at $33.04 ($261,813) on September 30, 2026; holds 141,989 after (Direct).
- Open-market sale: disposed of 2,075 Common Stock at $33.76 ($70,043) on September 30, 2026; holds 139,914 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $331,856 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Cheryl Gault — Officer (Chief Operating Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-30 | Open-market sale | Common Stock | 7,925 | $33 | $261.8K | 141,989 |
| 2026-09-30 | Open-market sale | Common Stock | 2,075 | $34 | $70.0K | 139,914 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-30 | Open-market sale (7,925 shares) |
| 2026-09-30 | Open-market sale (2,075 shares) |
Keywords
insider transaction, Form 4, RAPP, Rapport Therapeutics, Inc., bearish, Cheryl Gault
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.